What is Catheter Precision?
Catheter Precision is a medical device company focused on electrophysiology, dedicated to improving the lives of patients affected by cardiac arrhythmias. The company has developed innovative products, including eIFU, Vivo, and LockeT, designed to advance patient care and outcomes in cardiac treatment. Their primary clientele consists of healthcare providers and medical professionals specializing in cardiac care, who benefit from Catheter Precision's commitment to meaningful innovation.
How much funding has Catheter Precision raised?
Catheter Precision has raised a total of $1.6M across 2 funding rounds:
Debt
$150K
Stock/Share Issuance
$1.5M
Debt (2020): $150K with participation from PPP
Stock/Share Issuance (2025): $1.5M, investors not publicly disclosed
Key Investors in Catheter Precision
PPP
Public-Private Partnership
What's next for Catheter Precision?
With the recent influx of major strategic investment, Catheter Precision is poised for accelerated growth and market expansion. The substantial enterprise-level funding suggests a strategic focus on scaling operations, further product development, and potentially broader market penetration. This capital infusion is expected to bolster their efforts in enhancing patient care for cardiac arrhythmias, solidifying their position as a key player in the electrophysiology landscape.
See full Catheter Precision company page
